Benjamin Halladay - 17 Jun 2025 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
17 Jun 2025
Net transactions value
-$8,328
Form type
4
Filing time
18 Jun 2025, 18:44:26 UTC
Previous filing
21 Apr 2025
Next filing
18 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Halladay Benjamin Chief Financial Officer C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR /s/ Sheldon L. Koenig, by power of attorney 18 Jun 2025 0001953943

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale $8,328 -7,229 -1.5% $1.15 474,473 17 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.